help@researchreport.co.uk

Point Of Care Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2028

  • Report ID : 100103
  • Category : Medical Devices
  • Pages : -----
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports

Point-of-care Diagnostic (POCD) is defined as medical diagnostic technology that can be used at the point of care i.e. wherever the patient is present. The diagnostic technique is very different from the traditional testing methods. In traditional diagnostic tests, the diagnostic tests were performed at their respective laboratories and patients had to wait for days for the results, point-of-care diagnostic involves bringing the diagnostic tools immediately and conveniently to the patient and providing rapid diagnosis in real time.

The driving notion of point-of-care diagnostic is its quick diagnostic techniques which allow faster treatment, medication and clinical management based  on the POCD results.. Point-Of-Care Diagnostics includes development in microfluidic, biosensors, assay formats, bio-analytical platforms, lab-on-a-chip technologies and complementary technologies.

Point-of-care diagnostic gathers the specimens and procure results in a short span of time, essentially near the location of the patient such that the cost of treatment is cheaper, quicker and more precise. From management of patient’s data to diagnosis and monitoring of a disease, POCD facilitates all of the tasks for a patient requiring rapid detection.

POCD also plays an important role in patient management, reducing the time required to treat an ailment and improves the ultimate outcome of patient’s health. Since, there are a vast number of point-of-care assays i.e. assays performed on patients, various biomarkers have been developed by deploying portable and simple in usage point-of-care clinical and biochemical analyzers. This is considered to be a revolutionary for many diseases, particularly the ones that require immediate assistance like ischemic stroke. Even for various other diseases, treatment and medical intervention at an early stage would be responsible for saving a lot of lives.

Some examples of equipment being used for improved Point-Of-Care Diagnostics includes label-free biosensors such as white light reflectance spectroscopy (WLRS) and Surface Plasmon Resonance (SPR). Complementary technologies such as system integration, microfluidics, lab-on-a-chip technologies, signal readout and device automation are propelling the Point-Of-Care Diagnostics towards continuous improvements over the forecast period.

Point-Of-Care Diagnostics disposed towards smart devices equipped with mobile healthcare (mH) is predicted to be the major trend in the market, since, this could be particularly revolutionary for POCD and personalized healthcare monitoring and management. Many promising mobile healthcare technologies have been developed that are being used for a readout of colorimetric, lateral flow, electrochemical, fluorescent, chemiluminescent , label-free assays, detection of cells, biomolecules, nanoparticles, and microorganisms and other diagnostic applications using the cellphone-based POC technologies.

It has been estimated that the number of cellphone users have passed 7.4 billion in emerging countries which is 70% of the total cellphone users and the population in these countries is marred by various communicable/non-communicable diseases. Hence, Point-Of-Care Diagnostics could be a revolutionary aid in treatment procedures in the region. Therefore, emerging countries is projected to be a highly profitable market for Point-of-Care Diagnostics.

Some of the major stakeholders in the Point-Of-Care Diagnostics market include various medical device manufacturing companies, companies distributing POCD equipment, clinical laboratories, hospitals, clinics and special areas such as sports and military fitness bodies, government /private research institutes and clinical research organizations (CROs). Establishment of an international cloud for ease in management of Big Data may hinder the market over the forecast period, since, the technology requires personal data of patients, therefore, effective measure would be required for security of privacy of data storage.

The POCD market is set to witness a rise owing to a global demand of a technology facilitating self-monitor and management of the personal health. Roche (Switzerland), Abbott (US) and Siemens (Germany) are the prominent players in Point-Of-Care Diagnostics acquiring the major share in the industry. Various other companies like Instrumentation Laboratory (US), Nova (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Quidel (US), EKF Diagnostics (UK), Chembio Diagnostics (US), Trinity Biotech (US), and AccuBioTech (China) are set to enter the market with their respective products for Point-of-Care Diagnostics.

Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.


Please Fill In The Customization Form With Your Requirements.


Help Center

Email Address : help@researchreport.co.uk

Help Center

Toll Free :+442037693786

More FAQ's